Updates are available Correction dated 2024-11-12
Click to view Correction: https://doi.org/10.1038/s41366-024-01670-9
-
Authors
Coppola, Serena https://orcid.org/0000-0003-0421-7904
Paparo, Lorella
Bedogni, Giorgio https://orcid.org/0000-0002-1495-9306
Nocerino, Rita
Costabile, Davide
Cuomo, Mariella
Chiariotti, Lorenzo
Carucci, Laura
Agangi, Annalisa
Napolitano, Marcello
Messina, Francesco
Passariello, Annalisa
Berni Canani, Roberto https://orcid.org/0000-0002-5169-9574
- License Information
-
More Information
Article History
Received: 7 March 2024
Revised: 26 August 2024
Accepted: 29 August 2024
First Online: 18 September 2024
Change Date: 8 November 2024
Change Type: Update
Change Details: The original online version of this article was revised. In the original version of the manuscript, we reported the results of the primary study outcome providing data on per-protocol analysis (PPA) and intention-to-treat analysis (ITT), assuming a best-case scenario (i.e., with MD children lost to follow-up (n = 5) assigned a positive outcome and with CT children lost to follow-up (n = 2) assigned a negative outcome), and a worst-case scenario (i.e., with MD children lost to follow-up (n = 5) assigned a negative outcome and with CT children lost to follow-up (n = 2) assigned a positive outcome). Subsequently, due to the length of the manuscript, Table 2 was revised with the aim of presenting only the worst-case scenario data of the ITT analysis. Unfortunately, due to a cut-and-paste error, in the manuscript as well as in Table 2 we stated that data were referring to worst-case scenario, whereas the data provided in the text referred to best-case scenario. Please be assured that this error does not affect the overall findings of the study. As confirmed by the PPA reporting that the absolute risk difference in overweight or obesity was -24% (95% CI -38% to -9%) for the MD arm in comparison to the CT arm, resulting in an NNT of 4 (95% CI 2 to 12), we feel that our conclusions remain valid: Mediterranean Diet has proven to be an effective strategy in preventing obesity in the offspring of women who completed the follow-up.
Change Date: 12 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41366-024-01670-9
Competing interests
: The authors declare no competing interests.
: The trial was approved by the Ethics Committee of the University of Naples Federico II and was conducted in accordance with the Helsinki Declaration and relevant European and Italian privacy regulations. Written informed consent to participate in the study was obtained from the women and no financial compensation was provided. The trial was registered on ClinicalTrials.gov (Identifier: NCT03337802). The study took place at the Villa Betania Evangelical Hospital in Naples, Italy, between November 30, 2017 and January 31, 2021. The study is reported following the Consolidated Standards of Reporting Trials (CONSORT) guidelines.
